Gout and Hyperuricaemia Causes
Gout and Hyperuricaemia Causes
Urate rises for two reasons — the body makes more of it, or the kidney clears less — and the second is the usual one. This page sets out where urate comes from and why humans are susceptible to it at all, why clearance fails, what genes and medicines contribute, and then the distinction patients find most useful of all: what causes the level to be high, versus what sets off an attack in a joint where crystals were already sitting.
Where urate comes from, and why humans are susceptible
Urate is the end product of purine breakdown. Purines come from the body's own cell turnover and from food; they are metabolised to hypoxanthine and xanthine and then to uric acid, which circulates dissolved in the blood at a concentration set by the balance between how much is produced and how much the kidney clears.
Most mammals do not have gout, because most mammals have uricase — an enzyme that breaks urate down further into allantoin, which is far more soluble and is excreted easily. Humans lost it during primate evolution. The consequence is that our urate levels run several times higher than those of almost any other mammal, and sit close enough to the saturation point that ordinary variation pushes a substantial share of the population over it.
That single fact explains most of what is otherwise confusing about this disease. It explains why diet has a real but limited effect — the level is set mainly by handling, not by intake. It explains why urate is so often high in people who eat perfectly sensibly. And it explains why the effective treatments work on the enzymes that produce urate and on the transporters that clear it, rather than on the food.
The usual problem: the kidney is not clearing enough
Urate is handled by the kidney in four steps — filtration, reabsorption, secretion, and reabsorption again — and the net result is set by transporters in the tubule rather than by filtration alone. In most people with gout, the problem is on that handling side: the tubule reabsorbs more urate than it should, or secretes less, and the level rises even though production is entirely normal.
The clinical signature is a normal diet, no obvious overproduction, a level that drifts upward over years, and often a family history. It is also the reason a uricosuric agent — which increases excretion — is the logical treatment where kidney function allows, and why reduced filtration from any cause raises urate as a consequence.
The relationship with the kidney runs in both directions, and this is the part worth stating plainly. Reduced filtration raises urate; and sustained high urate, along with the hypertension and diuretic use that so often accompany it, is itself hard on the kidney. Which came first is often unanswerable after the fact, and it does not change what should be done — kidney function and urate are tracked together, and both are treated.
Overproduction exists, and it is worth identifying where it is present, because it changes the treatment: heavy purine or alcohol intake, fructose-rich drinks, rapid cell turnover from psoriasis or a myeloproliferative condition, tumour lysis during cancer treatment, and the rare specific enzyme defects. A 24-hour urine collection separates it from under-excretion, and it is the reason that test appears in the assessment rather than being reserved for unclear cases.
Genes, and how much they load the dice
The urate level a person runs is substantially heritable. Variants in the transporter genes that govern tubular handling — SLC2A9 and ABCG2 among the most studied — shift the level in either direction, and a family history of gout is one of the strongest risk factors in the whole condition.
Two things follow, and both are worth saying to patients who have just been diagnosed. The first is that a family history is useful information rather than a verdict: it changes how early the level is measured and how seriously a borderline result is taken. The second is that genes load the dice without fixing the outcome — the same variants with a different weight, a different medicines list and a different kidney produce a different disease, which is why the modifiable parts of this condition are worth modifying.
Gout also travels with a set of conditions that have their own genetic component: metabolic syndrome, hypertension, type 2 diabetes and chronic kidney disease. Finding gout is often the occasion on which the rest of that pattern is looked for properly for the first time, and for many patients that is the more valuable consequence of the diagnosis.
Medicines and diseases that raise urate
This is the most productive section of the causes page, because it describes the causes most often present and most often overlooked. A medicine prescribed years earlier for an unrelated problem is one of the commonest reversible drivers of a high urate level.
| Source | How it raises urate | What can be done |
|---|---|---|
| Thiazide and loop diuretics | Increase tubular reabsorption of urate, and often cause mild volume depletion which does the same | Tell the prescriber; a substitute for blood pressure often exists. Do not stop a heart or blood pressure medicine on your own |
| Low-dose aspirin | At low doses it reduces urate excretion; at high doses it does the opposite, which is why the effect looks paradoxical | Usually continued where it is prescribed for a vascular indication; the urate target is then reached with more of the other medicine |
| Ciclosporin | Reduces urate excretion and is often given alongside a diuretic | Reviewed with the transplant or rheumatology team rather than changed independently |
| Pyrazinamide and ethambutol | Anti-tuberculosis medicines that raise urate markedly and commonly provoke attacks | Managed with the treating team; attack treatment is planned in advance rather than discovered |
| Reduced kidney function, from any cause | Less filtration leaves urate behind | Urate and filtration tracked together; doses adjusted to function |
| Psoriasis, myeloproliferative disease, tumour lysis | Rapid cell turnover produces more purine than the kidney can clear | Treat the underlying condition; urate lowering supports it rather than replaces it |
The practical rule is a list rather than a prohibition. Keep one, including supplements and anything bought without a prescription, take it to every appointment, and ask specifically whether each item is affecting the urate level. That question takes a minute to answer and is one of the highest-yield things a patient can do.
What triggers an attack, as opposed to what causes the disease
This is the distinction patients find most clarifying, and it is rarely made explicitly. The cause of gout is a level that has been above saturation long enough for crystals to form. The trigger is whatever makes crystals already sitting in a joint shed into the joint space and provoke inflammation. Removing triggers reduces attacks; only lowering the level removes the disease.
| Trigger | What it does | What can be done |
|---|---|---|
| Dehydration and acute illness | Less water through the kidney means less urate cleared, and the concentration rises | Fluid during illness; a plan for which medicines to pause during vomiting or diarrhoea |
| Alcohol, particularly a binge | Reduces excretion and adds purine where beer is involved | Frequency and quantity both matter; the binge pattern triggers more reliably than steady moderate drinking |
| A large purine-rich meal | Acute rise in the load the kidney has to clear | Moderation rather than exclusion; the effect is real but smaller than most patients assume |
| Injury, surgery or a long period on the feet | Local tissue change and mechanical stress make crystals shed | Known and anticipated, particularly around planned surgery |
| Starting or changing urate-lowering therapy | A falling level mobilises crystals, which provokes attacks — the reason prophylaxis is used | Covered with anti-inflammatory prophylaxis for the first months, and explained in advance |
| Rapid weight loss or crash dieting | Ketosis competes with urate for excretion, and the level rises | Steady loss; warn patients that the healthy change can trigger an attack early on |